Cellectar Biosciences, Inc. Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31)
Cellectar Biosciences, Inc. (CLRB) reported Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) of $6.04 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-15.
Discontinued › Notes
us-gaap:IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments · last filed 2013-05-15
- Cellectar Biosciences, Inc. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $6.04K.
- Cellectar Biosciences, Inc. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for the quarter ending 2012-12-31 was $8.32K, a 84.77% decline year-over-year.
- Cellectar Biosciences, Inc. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for the quarter ending 2012-09-30 was $3.90K, a 9.21% increase year-over-year.
- Cellectar Biosciences, Inc. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for the quarter ending 2012-06-30 was -$17.23K.
- Cellectar Biosciences, Inc. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for fiscal 2012 was -$33.85K.
- Cellectar Biosciences, Inc. increase (decrease) in fair value of derivative instruments, not designated as hedging instruments (deprecated 2013-01-31) for fiscal 2011 was -$12.16K.
| Period end | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 3 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 6 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 9 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 12 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 104 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 107 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 110 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 113 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 116 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 119 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 122 month | Increase (Decrease) in Fair Value of Derivative Instruments, Not Designated as Hedging Instruments (Deprecated 2013-01-31) 125 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-03-31 | $6.04K 10-Q · filed 2013-05-15 | $14.37K derived: sum of 2 quarters · filed 2013-05-15 | $18.27K derived: sum of 3 quarters · filed 2013-05-15 | $1.03K derived: sum of 4 quarters · filed 2013-05-15 | -$39.97K 10-Q · filed 2013-05-15 | |||||||
| 2012-12-31 | $8.32K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $12.23K derived: sum of 2 quarters · filed 2013-03-28 | -$5.01K derived: sum of 3 quarters · filed 2013-03-28 | -$33.85K 10-K · filed 2013-03-28 | -$46.01K 10-K · filed 2013-03-28 | |||||||
| 2012-09-30 | $3.90K 10-Q · filed 2012-11-06 | -$13.33K derived: sum of 2 quarters · filed 2012-11-06 | -$42.18K 10-Q · filed 2012-11-06 | $12.48K derived: sum of 4 quarters · filed 2013-05-15 | -$54.34K 10-Q · filed 2012-11-06 | |||||||
| 2012-06-30 | -$17.23K 10-Q · filed 2012-08-09 | -$46.08K 10-Q · filed 2012-08-09 | $8.58K derived: sum of 3 quarters · filed 2013-05-15 | $12.15K derived: sum of 4 quarters · filed 2013-05-15 | -$58.24K 10-Q · filed 2012-08-09 | |||||||
| 2012-03-31 | -$28.85K 10-Q · filed 2013-05-15 | $25.82K derived: sum of 2 quarters · filed 2013-05-15 | $29.39K derived: sum of 3 quarters · filed 2013-05-15 | -$41.00K derived: sum of 4 quarters · filed 2013-05-15 | -$41.00K 10-Q · filed 2012-05-04 | |||||||
| 2011-12-31 | $54.66K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $58.23K derived: sum of 2 quarters · filed 2013-03-28 | -$12.16K derived: sum of 3 quarters · filed 2013-03-28 | -$12.16K 10-K · filed 2013-03-28 | -$12.16K 10-K · filed 2012-03-09 | |||||||
| 2011-09-30 | $3.57K 10-Q · filed 2012-11-06 | -$66.82K derived: sum of 2 quarters · filed 2012-11-06 | -$66.82K 10-Q · filed 2012-11-06 | -$66.82K 10-Q · filed 2011-11-07 | ||||||||
| 2011-06-30 | -$70.39K 10-Q · filed 2012-08-09 | -$70.39K 10-Q · filed 2012-08-09 | -$70.39K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |